I agree that this site is using cookies. You can find further informations here.
X
López-Cabra, C.
118  results:
Search for persons X
?
1

EE168 Avoidable Costs in Patients with Metastatic Hormone S..:

Roa, M ; López-Cabra, C. ; Torres, L...
Value in Health.  27 (2024)  6 - p. S88 , 2024
Link: https://doi.org/10.1016/..
 
?
2

EE269 Direct Medical Costs in Patients with Metastatic Horm..:

Roa, M ; López-Cabra, C. ; Torres, L...
Value in Health.  27 (2024)  6 - p. S106-S107 , 2024
Link: https://doi.org/10.1016/..
 
?
3

EE328 Direct Medical Costs in Patients with Non-Metastatic ..:

López-Cabra, C. ; Roa, M ; Torres, L...
Value in Health.  27 (2024)  6 - p. S118 , 2024
Link: https://doi.org/10.1016/..
 
?
4

EE549 Burden of Disease of Chronic Kidney Disease (CKD) in ..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S159-S160 , 2023
Link: https://doi.org/10.1016/..
 
?
5

EE425 Impact of Inclusion of Finerenone in the Burden of Ch..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S137 , 2023
Link: https://doi.org/10.1016/..
 
?
6

EE80 Burden of Disease of Chronic Kidney Disease (CKD) in T..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S74 , 2023
Link: https://doi.org/10.1016/..
 
?
7

EE196 Impact of Inclusion of Finerenone in the Burden of Di..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S95 , 2023
Link: https://doi.org/10.1016/..
 
?
8

EE423 Impact of Inclusion of Finerenone in the Burden of Di..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S137 , 2023
Link: https://doi.org/10.1016/..
 
?
9

EE311 Burden of Disease of Chronic Kidney Disease (CKD) in ..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S116 , 2023
Link: https://doi.org/10.1016/..
 
?
10

EE547 Impact of Inclusion of Finerenone in the Burden of Di..:

López-Cabra, C. ; Rodríguez, Á.D. ; Mayorga Mogollon, W....
Value in Health.  26 (2023)  6 - p. S159 , 2023
Link: https://doi.org/10.1016/..
 
?
11

EE223 Impact of Inclusion of Vericiguat in the Burden of Di..:

López-Cabra, C. ; Lasalvia, P. ; Rey, S.J....
Value in Health.  26 (2023)  6 - p. S100 , 2023
Link: https://doi.org/10.1016/..
 
?
12

ASSESSMENT OF DIAGNOSTIC TOOLS USED TO IDENTIFY PATIENTS WI..:

Lopez-Cabra, C. ; Reyes, J.M. ; Prieto, V.A.
Value in Health.  19 (2016)  3 - p. A308 , 2016
Link: https://doi.org/10.1016/..
 
?
13

Economic Evaluation of Sunitinib as First-Line Treatment fo..:

Prieto, VA ; Reyes, JM ; Lopez-Cabra, C..
Value in Health.  19 (2016)  3 - p. A149 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Depression and Coronary Heart Disease Risk: An Overview of ..:

Reyes, Jm ; Gutierrez-Ardila, MV ; Lopez-Cabra, C
Value in Health.  19 (2016)  3 - p. A43 , 2016
Link: https://doi.org/10.1016/..
 
?
15

Possible Genetic Determinants of Response to Phenytoin in a..:

Calderon-Ospina, Carlos-Alberto ; Galvez, J. M ; López-Cabra, C...
16639812.  , 2020
Link: https://repository.urosa..
 
1-15